Module 5: Mechanism of Action (MOA) of Immunoglobulin (IG) Treatment in Primary Immunodeficiency

This module of the Rare Disease Immunology course explains the mechanism of action (MOA) by which immunoglobulin therapy (IG) effectively treats patients with primary immunodeficiency (PI).

The module includes an overview of PI as a disease state, the management of PI with IG treatment, and how IG replacement works in treating antibody production deficiency.

Upon completion of this module, you should be able to:

• Describe PI in terms of antibody production deficiency
• Explain the MOA by which IG replacement is used to treat patients with PI with antibody deficiencies

This module takes approximately 30 minutes to complete.